
Regarding the end of enrollment of subjects in the Japanese clinical phase III study for patients with the new coronavirus infection, the anti-influenza virus drug “Avigan ® Tablets” FUJIFILM Toyama Chemical Co., Ltd. (Headquarters: Chuo-ku, Tokyo / President: Junji Okada, hereafter FUJIFILM Toyama Chemical) has announced the anti-influenza virus drug “Avigan ® Tablets” (generic name: […]